title: Merlin facilitates ubiquitination and degradation of transactivation-responsive RNA-binding protein.
abstract: The Nf2 tumor suppressor codes for merlin, a protein whose function is largely unknown. We have previously demonstrated a novel interaction between merlin and TRBP, which inhibits the oncogenic activity of TRBP. In spite of the significance of their functional interaction, its molecular mechanism still remains to be elucidated. In this report, we investigated how merlin inhibits the oncogenic activity of TRBP in association with cell growth conditions. In the human embryonic kidney 293 cell line, the level of endogenous merlin increased, whereas that of endogenous TRBP significantly decreased along with the increase in cell confluence. We demonstrated that the carboxyl-terminal region of TRBP was responsible for this phenomenon using stable cell lines expressing deletion mutants of TRBP. The overexpression of merlin decreased the protein level of TRBP, and the ubiquitin-like subdomain of merlin's FERM domain was important for this activity. We also demonstrated that TRBP is ubiquitinylated and the ubiquitinylated forms of TRBP are accumulated by ectopically expressed merlin or cell confluence in the presence of MG132, a proteasome inhibitor. Furthermore, we showed that the regulation of TRBP in response to cell confluence was abolished upon knockdown of merlin expression by specific small interfering RNA. Finally, we showed that ectopically expressed merlin restored cell-cell contact inhibition in cells stably expressing TRBP but not in TRBPDeltac. These results suggest that merlin is involved in the regulation of TRBP protein level by facilitating its ubiquitination in response to such cues as cell-cell contacts.
authors.affiliation: Catholic Neuroscience Center, The Catholic University of Korea, Seoul, Korea.
authors.forename: J Y
authors.initials: JY
authors.lastname: Lee
authors.forename: H J
authors.initials: HJ
authors.lastname: Moon
authors.forename: W K
authors.initials: WK
authors.lastname: Lee
authors.forename: H J
authors.initials: HJ
authors.lastname: Chun
authors.forename: C W
authors.initials: CW
authors.lastname: Han
authors.forename: Y-W
authors.initials: YW
authors.lastname: Jeon
authors.forename: Y
authors.initials: Y
authors.lastname: Lim
authors.forename: Y H
authors.initials: YH
authors.lastname: Kim
authors.forename: T-P
authors.initials: TP
authors.lastname: Yao
authors.forename: K-H
authors.initials: KH
authors.lastname: Lee
authors.forename: T-Y
authors.initials: TY
authors.lastname: Jun
authors.forename: H K
authors.initials: HK
authors.lastname: Rha
authors.forename: J-K
authors.initials: JK
authors.lastname: Kang
mesh_terms: D000818:Animals; D015153:Blotting, Western; D002448:Cell Adhesion; D006801:Humans; D047468:Immunoprecipitation; D007668:Kidney / Q000166:cytology / Q000378:metabolism; D007976:Leupeptins / Q000494:pharmacology; D051379:Mice; D041681:NIH 3T3 Cells; D025581:Neurofibromin 2 / Q000037:antagonists & inhibitors / Q000235:genetics / Q000378:metabolism*; D034741:RNA, Small Interfering / Q000494:pharmacology; D016601:RNA-Binding Proteins / Q000235:genetics / Q000378:metabolism*; D017384:Sequence Deletion; D015533:Transcriptional Activation; D014162:Transfection; D025801:Ubiquitin / Q000378:metabolism*; D000099253:Trans-Activation Responsive RNA-Binding Protein
chemical_list: D007976:Leupeptins; D025581:Neurofibromin 2; D034741:RNA, Small Interfering; D016601:RNA-Binding Proteins; D025801:Ubiquitin; D000099253:Trans-Activation Responsive RNA-Binding Protein; C072553:benzyloxycarbonylleucyl-leucyl-leucine aldehyde